Prevalence of diabetes mellitus in patients with home enteral nutrition

Abuín-Fernández, José; Doulatram-Gamgaram, Viyey; Sánchez-Torralvo, Francisco José; Contreras-Bolívar, Victoria; Padín, Susana; Gonzalo-Marín, Montserrat; Olveira, Gabriel

doi:10.1016/j.endinu.2019.11.001

Cited by 4 publications

(1 citation statement)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Expert recommendations recognise that there are few studies that evaluate the prevalence of hyperglycaemia in patients receiving EN, with reported values ranging from 30% to 47% and with half of the patients lacking a previous diagnosis of diabetes mellitus (DM) [3,4]. Abuin-Fernandez (2020) estimated the prevalence of DM to be 31.8% for patients receiving home enteral nutrition (HEN) through a feeding tube [5]. For patients receiving medical nutrition therapy, hyperglycaemia has been associated with increased morbidity and mortality [6,7].…”

Section: Introductionmentioning

confidence: 99%

Standards for the Use of Enteral Nutrition in Patients with Diabetes or Stress Hyperglycaemia: Expert Consensus

Rebollo-Pérez,

Florencio Ojeda,

García-Luna

et al. 2023

Nutrients

Self Cite

View full text Add to dashboard Cite

(1) Background: Hyperglycaemia that occurs during enteral nutrition (EN) should be prevented and treated appropriately since it can have important consequences for morbidity and mortality. However, there are few quality studies in the literature regarding the management of EN in this situation. The objective of this project was to attempt to respond, through a panel of experts, to those clinical problems regarding EN in patients with diabetes or stress hyperglycaemia (hereinafter referred to only as hyperglycaemia) for which we do not have conclusive scientific evidence; (2) Methods: The RAND/UCLA Appropriateness Method, a modified Delphi panel method, was applied. A panel of experts made up of 10 clinical nutrition specialists was formed, and they scored on the appropriateness of EN in hyperglycaemia, doing so in two rounds. A total of 2992 clinical scenarios were examined, which were stratified into five chapters: type of formula used, method of administration, infusion site, treatment of diabetes, and gastrointestinal complications. (3) Results: consensus was detected in 36.4% of the clinical scenarios presented, of which 23.7% were deemed appropriate scenarios, while 12.7% were deemed inappropriate. The remaining 63.6% of the scenarios were classified as uncertain; (4) Conclusions: The recommendations extracted will be useful for improving the clinical management of these patients. However, there are still many uncertain scenarios reflecting that the criteria for the management of EN in hyperglycaemia are not completely standardised. More studies are required to provide quality recommendations in this area.

show abstract